 | • レポートコード：GIR-22F17892 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Human Acellular Vessels (HAVs) Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界のヒト無細胞血管（HAV）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ヒト無細胞血管（HAV）市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・ePTFE 血管移植片、ポリエステル血管移植片、PTFE 血管移植片、その他 アプリケーション別セグメントは次のように区分されます。 ・心血管疾患、動脈瘤、血管閉塞、その他 世界のヒト無細胞血管（HAV）市場の主要な市場プレーヤーは以下のとおりです。 ・Getinge Group、Bard、Terumo、W. L. Gore、JUNKEN MEDICAL、B.Braun、LeMaitre、Shanghai Suokang、Shanghai Chest Medical、Maquet、Wuhan Yangsen、Vascutek、Jotec Gmbh、InterVAscular、Atrium Medical 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ヒト無細胞血管（HAV）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なヒト無細胞血管（HAV）メーカーの企業概要、2019年～2022年までのヒト無細胞血管（HAV）の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なヒト無細胞血管（HAV）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別ヒト無細胞血管（HAV）の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのヒト無細胞血管（HAV）のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのヒト無細胞血管（HAV）市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびヒト無細胞血管（HAV）の産業チェーンを掲載しています。 ・第13、14、15章では、ヒト無細胞血管（HAV）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - ヒト無細胞血管（HAV）の概要 - タイプ別分析（2017年vs2021年vs2028年）：ePTFE 血管移植片、ポリエステル血管移植片、PTFE 血管移植片、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：心血管疾患、動脈瘤、血管閉塞、その他 - 世界のヒト無細胞血管（HAV）市場規模・予測 - 世界のヒト無細胞血管（HAV）生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Getinge Group、Bard、Terumo、W. L. Gore、JUNKEN MEDICAL、B.Braun、LeMaitre、Shanghai Suokang、Shanghai Chest Medical、Maquet、Wuhan Yangsen、Vascutek、Jotec Gmbh、InterVAscular、Atrium Medical ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：ePTFE 血管移植片、ポリエステル血管移植片、PTFE 血管移植片、その他 ・アプリケーション別分析2017年-2028年：心血管疾患、動脈瘤、血管閉塞、その他 ・ヒト無細胞血管（HAV）の北米市場分析 - ヒト無細胞血管（HAV）の北米市場：タイプ別市場規模2017年-2028年 - ヒト無細胞血管（HAV）の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ヒト無細胞血管（HAV）のヨーロッパ市場分析 - ：ヒト無細胞血管（HAV）のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：ヒト無細胞血管（HAV）のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ヒト無細胞血管（HAV）のアジア太平洋市場分析 - ヒト無細胞血管（HAV）のアジア太平洋市場：タイプ別市場規模2017年-2028年 - ヒト無細胞血管（HAV）のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ヒト無細胞血管（HAV）の南米市場分析 - ヒト無細胞血管（HAV）の南米市場：タイプ別市場規模2017年-2028年 - ヒト無細胞血管（HAV）の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ヒト無細胞血管（HAV）の中東・アフリカ市場分析 - ヒト無細胞血管（HAV）の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - ヒト無細胞血管（HAV）の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Human Acellular Vessels (HAVs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Acellular Vessels (HAVs) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Cardiovascular Diseases accounting for % of the Human Acellular Vessels (HAVs) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While ePTFE Vascular Graft segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Acellular Vessels (HAVs) include Getinge Group, Bard, Terumo, W. L. Gore, and JUNKEN MEDICAL, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Acellular Vessels (HAVs) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ePTFE Vascular Graft
Polyester Vascular Graft
PTFE Vascular Graft
Others
Market segment by Application can be divided into
Cardiovascular Diseases
Aneurysm
Vascular Occlusion
Others
The key market players for global Human Acellular Vessels (HAVs) market are listed below:
Getinge Group
Bard
Terumo
W. L. Gore
JUNKEN MEDICAL
B.Braun
LeMaitre
Shanghai Suokang
Shanghai Chest Medical
Maquet
Wuhan Yangsen
Vascutek
Jotec Gmbh
InterVAscular
Atrium Medical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Acellular Vessels (HAVs) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Acellular Vessels (HAVs), with price, sales, revenue and global market share of Human Acellular Vessels (HAVs) from 2019 to 2022.
Chapter 3, the Human Acellular Vessels (HAVs) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Acellular Vessels (HAVs) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Acellular Vessels (HAVs) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Acellular Vessels (HAVs).
Chapter 13, 14, and 15, to describe Human Acellular Vessels (HAVs) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Human Acellular Vessels (HAVs) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Acellular Vessels (HAVs) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 ePTFE Vascular Graft
1.2.3 Polyester Vascular Graft
1.2.4 PTFE Vascular Graft
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Acellular Vessels (HAVs) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cardiovascular Diseases
1.3.3 Aneurysm
1.3.4 Vascular Occlusion
1.3.5 Others
1.4 Global Human Acellular Vessels (HAVs) Market Size & Forecast
1.4.1 Global Human Acellular Vessels (HAVs) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Acellular Vessels (HAVs) Sales in Volume (2017-2028)
1.4.3 Global Human Acellular Vessels (HAVs) Price (2017-2028)
1.5 Global Human Acellular Vessels (HAVs) Production Capacity Analysis
1.5.1 Global Human Acellular Vessels (HAVs) Total Production Capacity (2017-2028)
1.5.2 Global Human Acellular Vessels (HAVs) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Acellular Vessels (HAVs) Market Drivers
1.6.2 Human Acellular Vessels (HAVs) Market Restraints
1.6.3 Human Acellular Vessels (HAVs) Trends Analysis
2 Manufacturers Profiles
2.1 Getinge Group
2.1.1 Getinge Group Details
2.1.2 Getinge Group Major Business
2.1.3 Getinge Group Human Acellular Vessels (HAVs) Product and Services
2.1.4 Getinge Group Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bard
2.2.1 Bard Details
2.2.2 Bard Major Business
2.2.3 Bard Human Acellular Vessels (HAVs) Product and Services
2.2.4 Bard Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Terumo
2.3.1 Terumo Details
2.3.2 Terumo Major Business
2.3.3 Terumo Human Acellular Vessels (HAVs) Product and Services
2.3.4 Terumo Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 W. L. Gore
2.4.1 W. L. Gore Details
2.4.2 W. L. Gore Major Business
2.4.3 W. L. Gore Human Acellular Vessels (HAVs) Product and Services
2.4.4 W. L. Gore Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 JUNKEN MEDICAL
2.5.1 JUNKEN MEDICAL Details
2.5.2 JUNKEN MEDICAL Major Business
2.5.3 JUNKEN MEDICAL Human Acellular Vessels (HAVs) Product and Services
2.5.4 JUNKEN MEDICAL Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 B.Braun
2.6.1 B.Braun Details
2.6.2 B.Braun Major Business
2.6.3 B.Braun Human Acellular Vessels (HAVs) Product and Services
2.6.4 B.Braun Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 LeMaitre
2.7.1 LeMaitre Details
2.7.2 LeMaitre Major Business
2.7.3 LeMaitre Human Acellular Vessels (HAVs) Product and Services
2.7.4 LeMaitre Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Shanghai Suokang
2.8.1 Shanghai Suokang Details
2.8.2 Shanghai Suokang Major Business
2.8.3 Shanghai Suokang Human Acellular Vessels (HAVs) Product and Services
2.8.4 Shanghai Suokang Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Shanghai Chest Medical
2.9.1 Shanghai Chest Medical Details
2.9.2 Shanghai Chest Medical Major Business
2.9.3 Shanghai Chest Medical Human Acellular Vessels (HAVs) Product and Services
2.9.4 Shanghai Chest Medical Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Maquet
2.10.1 Maquet Details
2.10.2 Maquet Major Business
2.10.3 Maquet Human Acellular Vessels (HAVs) Product and Services
2.10.4 Maquet Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Wuhan Yangsen
2.11.1 Wuhan Yangsen Details
2.11.2 Wuhan Yangsen Major Business
2.11.3 Wuhan Yangsen Human Acellular Vessels (HAVs) Product and Services
2.11.4 Wuhan Yangsen Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Vascutek
2.12.1 Vascutek Details
2.12.2 Vascutek Major Business
2.12.3 Vascutek Human Acellular Vessels (HAVs) Product and Services
2.12.4 Vascutek Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Jotec Gmbh
2.13.1 Jotec Gmbh Details
2.13.2 Jotec Gmbh Major Business
2.13.3 Jotec Gmbh Human Acellular Vessels (HAVs) Product and Services
2.13.4 Jotec Gmbh Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 InterVAscular
2.14.1 InterVAscular Details
2.14.2 InterVAscular Major Business
2.14.3 InterVAscular Human Acellular Vessels (HAVs) Product and Services
2.14.4 InterVAscular Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Atrium Medical
2.15.1 Atrium Medical Details
2.15.2 Atrium Medical Major Business
2.15.3 Atrium Medical Human Acellular Vessels (HAVs) Product and Services
2.15.4 Atrium Medical Human Acellular Vessels (HAVs) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Acellular Vessels (HAVs) Breakdown Data by Manufacturer
3.1 Global Human Acellular Vessels (HAVs) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Acellular Vessels (HAVs) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Acellular Vessels (HAVs)
3.4 Market Concentration Rate
3.4.1 Top 3 Human Acellular Vessels (HAVs) Manufacturer Market Share in 2021
3.4.2 Top 6 Human Acellular Vessels (HAVs) Manufacturer Market Share in 2021
3.5 Global Human Acellular Vessels (HAVs) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Acellular Vessels (HAVs) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Acellular Vessels (HAVs) Market Size by Region
4.1.1 Global Human Acellular Vessels (HAVs) Sales in Volume by Region (2017-2028)
4.1.2 Global Human Acellular Vessels (HAVs) Revenue by Region (2017-2028)
4.2 North America Human Acellular Vessels (HAVs) Revenue (2017-2028)
4.3 Europe Human Acellular Vessels (HAVs) Revenue (2017-2028)
4.4 Asia-Pacific Human Acellular Vessels (HAVs) Revenue (2017-2028)
4.5 South America Human Acellular Vessels (HAVs) Revenue (2017-2028)
4.6 Middle East and Africa Human Acellular Vessels (HAVs) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Acellular Vessels (HAVs) Sales in Volume by Type (2017-2028)
5.2 Global Human Acellular Vessels (HAVs) Revenue by Type (2017-2028)
5.3 Global Human Acellular Vessels (HAVs) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Acellular Vessels (HAVs) Sales in Volume by Application (2017-2028)
6.2 Global Human Acellular Vessels (HAVs) Revenue by Application (2017-2028)
6.3 Global Human Acellular Vessels (HAVs) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Acellular Vessels (HAVs) Sales by Type (2017-2028)
7.2 North America Human Acellular Vessels (HAVs) Sales by Application (2017-2028)
7.3 North America Human Acellular Vessels (HAVs) Market Size by Country
7.3.1 North America Human Acellular Vessels (HAVs) Sales in Volume by Country (2017-2028)
7.3.2 North America Human Acellular Vessels (HAVs) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Acellular Vessels (HAVs) Sales by Type (2017-2028)
8.2 Europe Human Acellular Vessels (HAVs) Sales by Application (2017-2028)
8.3 Europe Human Acellular Vessels (HAVs) Market Size by Country
8.3.1 Europe Human Acellular Vessels (HAVs) Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Acellular Vessels (HAVs) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Acellular Vessels (HAVs) Sales by Type (2017-2028)
9.2 Asia-Pacific Human Acellular Vessels (HAVs) Sales by Application (2017-2028)
9.3 Asia-Pacific Human Acellular Vessels (HAVs) Market Size by Region
9.3.1 Asia-Pacific Human Acellular Vessels (HAVs) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Acellular Vessels (HAVs) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Acellular Vessels (HAVs) Sales by Type (2017-2028)
10.2 South America Human Acellular Vessels (HAVs) Sales by Application (2017-2028)
10.3 South America Human Acellular Vessels (HAVs) Market Size by Country
10.3.1 South America Human Acellular Vessels (HAVs) Sales in Volume by Country (2017-2028)
10.3.2 South America Human Acellular Vessels (HAVs) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Acellular Vessels (HAVs) Sales by Type (2017-2028)
11.2 Middle East & Africa Human Acellular Vessels (HAVs) Sales by Application (2017-2028)
11.3 Middle East & Africa Human Acellular Vessels (HAVs) Market Size by Country
11.3.1 Middle East & Africa Human Acellular Vessels (HAVs) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Acellular Vessels (HAVs) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Acellular Vessels (HAVs) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Acellular Vessels (HAVs)
12.3 Human Acellular Vessels (HAVs) Production Process
12.4 Human Acellular Vessels (HAVs) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Acellular Vessels (HAVs) Typical Distributors
13.3 Human Acellular Vessels (HAVs) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer